These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids. Wolthers OD, Heuck C. Allergy; 2004 Nov; 59(11):1193-7. PubMed ID: 15461601 [Abstract] [Full Text] [Related]
3. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler. Gradman J, Wolthers OD. Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635 [Abstract] [Full Text] [Related]
4. Methodology and implications of knemometry in growth assessment of inhaled glucocorticoids. Wolthers OD. Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e190-8. PubMed ID: 19422602 [Abstract] [Full Text] [Related]
5. Body composition and growth in asthmatic children treated with inhaled steroids. Salvatoni A, Nosetti L, Broggini M, Nespoli L. Ann Allergy Asthma Immunol; 2000 Sep; 85(3):221-6. PubMed ID: 11030277 [Abstract] [Full Text] [Related]
6. Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial. Wolthers OD, Stone S, Bareille P, Tomkins S, Khindri S. Clin Ther; 2017 Jun; 39(6):1191-1199. PubMed ID: 28545804 [Abstract] [Full Text] [Related]
7. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. Pedersen S, Agertoft L, Williams-Herman D, Kuznetsova O, Reiss TF, Knorr B, Dass SB, Wolthers OD. Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605 [Abstract] [Full Text] [Related]
8. A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β₂-Agonists. Wolthers OD, Shah T. J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):182-8. PubMed ID: 25166221 [Abstract] [Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [Abstract] [Full Text] [Related]
14. [Longitudinal growth in children with asthma treated with inhaled glucocorticoids]. Gradman J, Wolthers OD. Ugeskr Laeger; 2006 Feb 27; 168(9):885-9. PubMed ID: 16513049 [Abstract] [Full Text] [Related]
15. Safety of long-acting beta2-agonists in the treatment of asthma. Cazzola M, Matera MG. Ther Adv Respir Dis; 2007 Oct 27; 1(1):35-46. PubMed ID: 19124346 [Abstract] [Full Text] [Related]
16. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Clin Ther; 2008 Aug 27; 30(8):1492-504. PubMed ID: 18803991 [Abstract] [Full Text] [Related]
17. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment]. Watanabe N, Makino S, Kihara N, Fukuda T. Arerugi; 2008 Dec 27; 57(12):1284-92. PubMed ID: 19169083 [Abstract] [Full Text] [Related]
18. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood. Vangveeravong M. J Med Assoc Thai; 2008 Oct 27; 91 Suppl 3():S115-23. PubMed ID: 19253506 [Abstract] [Full Text] [Related]